Richard I. Gregory. Ph.D. is Professor and Stem Cell Biology Chair, in the Departments of Pediatrics, and Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He is Principal Investigator in The Stem Cell Program in the Division of Hematology/Oncology at Boston Children’s Hospital. He is co-Director and executive committee member of the Harvard Initiative for RNA Medicine, and Principal faculty member of The Harvard Stem Cell Institute. Research in the Gregory laboratory is focused on understanding the molecular and cellular mechanisms of RNA regulation and the relevance of these pathways in stem cell biology, development, and human diseases including cancer.
He is a recipient of an Outstanding Investigator Award from the National Cancer Institute. He is committed to exploiting fundamental discoveries for the development of new and effective therapies and is a co-founder and scientific advisory board member of Twentyeight-Seven Therapeutics, a biotechnology company that is developing cancer drugs that target RNA pathways.